Chris Price

Healthcare Investor

📍 United States🔄 Updated September 2026💼 1 investments📅 10 years investing🗓 Last invested Dec 2016
VC🌍 United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
10y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor, LDI Integrated Pharmacy Services
Dec 2016
CastiaRx is the industry’s leading specialty benefit manager. Combining full-service pharmacy benefit manager capabilities with specialty expertise, CastiaRx addresses spend across medical and pharmacy benefits. The company leads with compassion, striving to simplify specialty treatment. Believe in better with CastiaRx —better treatment, better care, and a better path to a healthier future. For more information, visit castiarx.com.
Experience · 7 entries
All (7)
Investments (1)
Founder (2)
2020
Founder & Managing Partner
Oct 2020
Epilog Partners is a private equity platform built by investors, operators and innovators for healthcares complexity. It invests in tech-enabled payer and provider services and software and tech-enabled pharma services companies that are improving clinical, financial, and experiential outcomes. Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Its efforts are guided by a research centric, thesis driven approach that informs where to invest and how to maximize value. This approach has resulted in completed platform investments, add-on acquisitions, recapitalizations and liquidity events with an aggregate transaction value of over $6 billion. Portfolio Companies: Care Connectors, CareMetx and ReceptRx (exited)
2018
Co-Founder, Investor & Chairman of Board
May 2018
WithMe Health is an innovative Pharmacy Benefit Manager (PBM) that puts members at the center of their healthcare experience. When members are engaged, everybody wins - leading to improved outcomes, lower cost of care, and reduced administrative burden for members, plan sponsors, and providers. Through WithMes clinically driven mPath360 technology and empathy-led medication guides, WithMe creates a truly personalized medication experience that connects the dots across the care spectrum. Our mission is to create a significantly better medication experience for all our members, putting their health and needs first as they navigate the complexity of medications by offering our clinical expertise to them and their trusted providers to save them money and to improve their health. Our pharmacist and pharma-tech Medication Guides are available to members 24/7 to provide medication counseling and guidance via our easy-to-use member app, live chat, and over the phone. To date, we’ve raised over $40 million from Oak HC/FT, OMERS Ventures, and other leading healthcare VCs and strategic partners to take on the $450+ billion PBM industry.
2016
Investor, LDI Integrated Pharmacy Services
Dec 2016
CastiaRx is the industry’s leading specialty benefit manager. Combining full-service pharmacy benefit manager capabilities with specialty expertise, CastiaRx addresses spend across medical and pharmacy benefits. The company leads with compassion, striving to simplify specialty treatment. Believe in better with CastiaRx —better treatment, better care, and a better path to a healthier future. For more information, visit castiarx.com.
Partner
Apr 2016
Oak HC/FT is a venture and growth equity firm investing in companies driving transformation in healthcare and fintech, two uniquely complementary and high-growth sectors. With deep domain expertise and strategic resources, Oak HC/FT partners with leading entrepreneurs at every stage, from seed to growth, to build businesses that make a measurable, lasting impact on these industries. Founded in 2014, the firm has $5.3 billion in assets under management. The partners at the firm have had 46 realizations and 35 companies achieving valuations in excess of $1 billion.
2010
Partner
2010
Broad Creek Partners is a research driven investment and advisory firm focused on the tech-enabled health care services sector. We invest between $2 and $20 million in existing seed to late stage companies or build new companies when we identify an unmet market need.
Show all 7 entries ↓